5881 - 5890 of 9140 Results
Title
Year
-
OPENTitle: Conopeptide-Functionalized Nanoparticles Selectively Antagonize Extrasynaptic N-Methyl-d-aspartate Receptors and Protect Hippocampal Neurons from Excitotoxicity In VitroJournal Name: ACS NanoPublisher: American Chemical Society (ACS)Vol: 14Issue #: 6Start Page: 6866End Page: 6877Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acsnano.0c00866Best OA location URL: https://ndownloader.figstatic.com/files/22969427Citation Count: 16
- Melatonin for Huntington's Disease (HD) gene carriers with HD-related sleep disturbance - A pilot study2025RESTRICTEDTitle: Melatonin for Huntington's Disease (HD) gene carriers with HD-related sleep disturbance - A pilot studyJournal Name: Sleep MedicinePublisher: Elsevier BVVol: 129Issue #:Start Page: 238End Page: 244Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.sleep.2025.02.032Citation Count: 7
-
OPENTitle: Wrinkle in the plan: miR-34a-5p impacts chemokine signaling by modulating CXCL10/CXCL11/CXCR3-axis in CD4+, CD8+ T cells, and M1 macrophagesJournal Name: Journal for ImmunoTherapy of CancerPublisher: BMJVol: 8Issue #: 2Start Page: e001617End Page: e001617Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1136/jitc-2020-001617Best OA location URL: https://jitc.bmj.com/content/jitc/8/2/e001617.full.pdfCitation Count: 49
- Serum L-ornithine-derived polyamines as indicators of Parkinson disease progression2025RESTRICTEDTitle: Serum L-ornithine-derived polyamines as indicators of Parkinson disease progressionJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 133Issue #: 7Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00702-025-03007-wCitation Count: 1
-
OPENTitle: Can Isolated Enlarged Virchow‐Robin Spaces Influence the Clinical Manifestations of Parkinson's Disease?Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 1Issue #: 1Start Page: 67End Page: 69Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12009Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12009Citation Count: 17
-
OPENTitle: Increased brain expression of GPNMB is associated with genome wide significant risk for Parkinson’s disease on chromosome 7p15.3Journal Name: neurogeneticsPublisher: Springer Science and Business Media LLCVol: 18Issue #: 3Start Page: 121End Page: 133Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1007/s10048-017-0514-8Best OA location URL: https://link.springer.com/content/pdf/10.1007%2Fs10048-017-0514-8.pdfCitation Count: 78
-
RESTRICTEDTitle: The metabotropic glutamate receptor 8 agonist (S)-3,4-DCPG reverses motor deficits in prolonged but not acute models of Parkinson's diseaseJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 66Issue #:Start Page: 187End Page: 195Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2012.03.029Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3432150Citation Count: 32
- Guanabenz promotes neuronal survival via enhancement of ATF4 and parkin expression in models of Parkinson disease2018RESTRICTEDTitle: Guanabenz promotes neuronal survival via enhancement of ATF4 and parkin expression in models of Parkinson diseaseJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 303Issue #:Start Page: 95End Page: 107Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2018.01.015Citation Count: 44
-
OPENTitle: Functional network differences between unilateral and bilateral deep brain stimulation of the subthalamic nucleusJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 215End Page: 215Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41531-025-01064-2Best OA location URL: https://www.nature.com/articles/s41531-025-01064-2.pdfCitation Count: 1
-
OPENTitle: AAV.shRNA-mediated downregulation of ROCK2 attenuates degeneration of dopaminergic neurons in toxin-induced models of Parkinson's disease in vitro and in vivoJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 73Issue #:Start Page: 150End Page: 162Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2014.09.013Best OA location URL: https://doaj.org/article/c2113aec27f04b79a88c4f5f1bf73ef8Citation Count: 70